News | News By Subject | News by Disease News By Date | Search News

Anti-fungal News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA: High Doses Of Pfizer Inc. (PFE)'s Antifungal Drug Fluconazole Might Cause Birth Defects     8/4/2011
European Experts Recommended Against Approving Novartis AG's Antifungal Drug Mycograb     11/17/2006
Schering-Plough Corporation (SGP) Announces FDA Approval Of NOXAFIL(R) (Posaconazole) For Prevention Of Invasive Fungal Infections     9/18/2006
Pfizer Inc. (PFE) Receives FDA Approval For Eraxis(TM) To Treat Candidemia, A Potentially Life-Threatening Bloodstream Infection     2/21/2006
Roche (RHHBY) Opting-Out Is Mixed News For Basilea Pharmaceutica; Basilea Pharmaceutica Maintains Global Commercialization Rights For BAL8557     12/19/2005
Barrier Therapeutics, Inc. (BTRX) Announces Phase 3 Results For Hyphanox(TM) In Vaginal Candidiasis; Product Fails To Meet Primary Endpoint Of Non-Inferiority Versus Fluconazole     6/30/2005
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval     3/17/2005
Icoria, Inc. (ICOR) Signs Licensing Agreement With Syngenta (SYT)     2/28/2005
Vicuron Pharmaceuticals, Inc. (MICU) Announces Phase 3 Trial Results Demonstrate Superiority Of Anidulafungin Versus Fluconazole In Invasive Candidiasis/Candidemia; Stocks Rise     2/7/2005
Eisai Company, Ltd. (ESALY.PK) Reacquires Worldwide Rights For A Triazole-Type Anti-Fungal Agent; Termination Of The Licensing Agreement With Bristol-Myers Squibb Company (BMY)     10/29/2004
NeuTec Pharma plc (NTP.L) To Raise $47.4M     7/23/2004
Vicuron Pharmaceuticals, Inc. (MICU) Announces 90-Day Extension Of FDA Review Of Anidulafungin New Drug Application     1/23/2004

News from Around the Web
Easier Diagnosis For Fungal Infection Of The Lungs, University of Exeter Study     1/19/2016
New Way For Early Detection Of Potentially Deadly Fungal Infection In Leukemia Patients Discovered, University of Texas Medical Branch at Galveston Researchers Reveal     12/15/2015
Coconut Oil May Combat Deadly Bloodstream Infection, Tufts University Study     11/19/2015
Lavender Oil has Potent Antifungal Effect, University of Coimbra Study     2/15/2011
Fungal Disease Culprits Identified With Molecular Genetics, Agricultural Research Service (ARS) Study     8/7/2008
Killer Fungus Goes Airborne     8/8/2007
Pfizer Inc. (PFE) (Jobs)'s New Antifungal Drug Eraxis 'Not Inferior' - Study     6/14/2007
Anti-Fungal Drug Itraconazole Stops Blood Vessel Growth, Johns Hopkins University School of Medicine Researchers Find     4/27/2007
Fungal Disease Killing L.A. Palm Trees     10/18/2006
The Day In Review: Schering-Plough Corporation (SGP) Gets Approval For Noxafil     9/18/2006
Lethal Power Of Rice Fungus Discovered     3/24/2006
Pregnancy Test May Lie Behind Deadly Frog Fungus     2/3/2006
New Method Enables Gene Disruption In Destructive Fungal Pathogen     2/2/2006
Deadly Fungus Gene Code Cracked     12/22/2005
Anti-Fungal Drug May Help Treat Cancer     6/29/2005

Press Releases
Basilea (BSLN.SW) Forges $491 Million+ Antifungal Deal With Drug Giant Pfizer (PFE)     6/14/2017
Viamet Data For VT-1161 And VT-1598 To Be Presented At American Society for Microbiology’s ASM Microbe 2017 Conference     5/17/2017
Blueberry Therapeutics Commence Phase I/II Clinical Trial Of Lead Product BB2603     4/25/2017
GenMark Diagnostics (GNMK) Achieves CE Mark For Its ePlex Blood Culture Identification Fungal Pathogen Panel     4/21/2017
Cidara (CDTX) To Present Data On Novel Antifungal CD101 And Cloudbreak Antibacterial Immunotherapy At ECCMID And SID Annual Meetings     4/17/2017
Luqa Pharmaceuticals Gains China Rights To Women's Anti-Fungal     3/31/2017
Newly Published Data Reinforce Growing Body Of Evidence Supporting Cidara (CDTX)’ Lead Antifungal CD101     12/14/2016
Cidara Therapeutics (CDTX) To Present Data On Lead Antifungal Product Candidate CD101 At Upcoming ASM Microbe 2016     6/8/2016
T2 Biosystems (TTOO) Release: Study Published In The American Journal Of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid And Accurate Diagnosis Of Candida, A Leading Cause Of Sepsis, In Pediatric Patients     6/3/2016
FDA Grants QIDP And Fast Track Designation To CD101 Topical, Cidara Therapeutics (CDTX)’ Novel Antifungal Product Candidate     5/31/2016
Cidara Therapeutics (CDTX) Announces Positive Data From Phase I Clinical Trial Of CD101 IV And Reports Third Quarter 2015 Financial Results     11/17/2015
Vical  (VICL) To Present Preclinical Data At ICAAC 2015 Meeting For Its Novel Antifungal Drug Candidate VL-2397     9/15/2015
Cidara Therapeutics (CDTX) Initiates Phase 1 Study Of Lead Antifungal Product Candidate CD101 IV     8/3/2015
SCYNEXIS, Inc. Announces Presentations of Data From Anti-Fungal Drug Candidate at the 50th ICAAC Meeting     9/14/2010
Barrier Therapeutics, Inc. (BTRX) Announces Promising Results From On-Going Phase 2a Study of Pramiconazole in Onychomycosis     10/19/2007